The State University of Campinas, commonly called Unicamp, is a public research university in the state of São Paulo, Brazil. Unicamp is consistently ranked among the top universities in Brazil and Latin America.

During the past decade, University of Campinas conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Campinas" #1 sponsor was "University of Campinas, Brazil" with 30 trials, followed by "Andrei Carvalho Sposito" with 1 trials sponsored, "Associazione Angela Serra per la ricerca sul cancro" with 1 trials sponsored, "Barretos Cancer Hospital" with 1 trials sponsored and "Instituto Dante Pazzanese de Cardiologia" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Campinas" #1 collaborator was "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 9 trials as a collaborator, "University of Campinas, Brazil" with 4 trials as a collaborator, "University of Brasilia" with 2 trials as a collaborator, "AC Camargo Cancer Center" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "University of Campinas" are "Healthy" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Heart Failure" (2 trials), "Hypertension" (2 trials) and "Abnormal Bleeding" (1 trials). Many other conditions were trialed in "University of Campinas" in a lesser frequency.

Most popular intervention types in "University of Campinas" are "Drug" (17 trials), "Other" (6 trials), "Device" (5 trials), "Dietary Supplement" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "LNG-IUS" (2 trials), "30 mcg EE and 150 LNG oral contraceptive (Microvlar)" (1 trials), "Achieva, Philips Medical Systems (3T magnet)" (1 trials), "Aerobic exercise in treadmill" (1 trials) and "Amlodipine" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Campinas" are 28 trials for "All" genders and 11 trials for "Female" genders.

Currently, there are NaN active trials in "University of Campinas". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in University of Campinas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Campinas, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 10 trials that are defined as “Not Applicable".